With a mix of nervousness and anticipation, I stepped into the vast atrium of the Los Angeles Convention Centre for the 2025 annual meeting, hosted by the American Society of Ophthalmic Administrators (ASOA). Running alongside the American Society of Cataract and Refractive Surgery (ASCRS) scientifi
In my early days of cane use I was always struck by people’s reaction to the thing. I suppose wheeling along three feet or so at the back end of a white stick separates the user a bit from the norm. The adults were a study on their own – everything from polite consideration to a wariness more suited
Following the recent ophthalmic nurses RANZCO NZ meeting in Rotorua, there has been ongoing discussion of how best to handle and dispose of substances used in ophthalmology, particularly intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapies and botulinum toxin (Botox or Dysport)
In the world of eyecare, precision and trust are everything. Whether you're diagnosing a complex vision issue or helping a patient choose their first pair of glasses, your work is built on accuracy, professionalism and care. But while clinical excellence is front of mind for most practices, one area
Is synaesthesia, a ‘crosstalk’ between the five senses producing extraordinary visual experiences, in fact a sixth sense?
With a shortage of ophthalmologists in the regions, RANZCO’s education committee surveyed 23 New Zealand-based ophthalmology trainees and a few recently made fellows to understand what mattered to them after they completed their training. Presenting the results at the RANZCO NZ 2025 conference in Ro
Researchers in the Molecular Vision Research Cluster (MVRC) at the University of Auckland are calling for eyecare professionals to refer a specific cohort of patients for a study they hope will result in new treatments for cataract and presbyopia.
The team behind the Vision Bus Aotearoa (VBA) is seeking new funding to support continued mobile eyecare service delivery to underserved schools, primarily in the South Auckland region. Funded entir
Ophthalmic nurse Kathryn Millichamp shares her highlights from RANZCO NZ 2025
Pharmac has swapped funding from nepafenac (Ilvero) to diclofenac sodium (Devatis) eye drops. Ilevro nepafenac drops were a temporary replacement for Voltaren Ophtha, for which there were supply gaps
Bringing together brilliant minds from NZ and further afield, RANZCO NZ Branch Meeting offered an abundance of new insights in ophthalmology.
Dr Peter Hadden fleshes out risks and benefits of new, promising treatments for melanomas and naevi